HOME >> BIOLOGY >> NEWS
Chemical link indicated between drinking and certain cancers

Researchers at the National Institute of Standards and Technology (NIST) have developed a new chemical analysis method that has assisted researchers at the National Institute of Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health, in demonstrating a potentially important chemical link between alcohol consumption and cancer. Using this novel chemical assay, they have uncovered a chain of chemical reactions that, under physiological conditions, may lead from alcohol to a known mutagen.

It has been known for years that there is a statistical relationship between excessive alcohol consumption and an increased risk of certain cancers, particularly upper gastrointestinal cancer. Alcohol itself is not a carcinogen but is metabolized in the body to form a suspected carcinogen, acetaldehyde (AA). Then the picture gets hazier. AA is known to react with 2'-deoxyguanosine (dG)--one of the chemical components of DNA--however, the main product does not appear to be mutagenic in mammals. It also is known that AA can react with DNA to produce a known mutagen (Cr-PdG. also known as alpha-methyl-gamma-hydroxy-1, N2-propano-2'-deoxyguanosine)--but only at very high concentrations of AA that would not occur in the human body.

The missing link, according to the NIAAA researchers, is a class of chemicals called polyamines that are produced in cells and believed to be involved in cell growth. Using a sensitive chemical analysis technique called liquid chromatography/isotope-dilution mass spectrometry developed at NIST, the team showed that AA reacts with polyamines to produce crotonaldehyde (CrA). This in turn reacts with dG in DNA to produce the mutagenic Cr-PdG.

An important finding was that the reactions occurred at concentrations of AA that can be found in human saliva after drinking alcohol, while concentrations of AA in gastrointestinal tissues can be even higher. The work strongly suggests that Cr-PdG plays a key role in the pathway between a
'"/>

Contact: Michael Baum
michael.baum@nist.gov
301-975-2763
National Institute of Standards and Technology (NIST)
10-Aug-2005


Page: 1 2

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Society meets Aug. 19-23 in Boston
3. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
4. News tips from ACS Chemical Biology
5. American Chemical Societys Weekly PressPac -- July 25, 2007
6. American Chemical Societys Weekly PressPac -- July 18, 2007
7. American Chemical Societys Weekly PressPac -- July 11, 2007
8. Wiley extends publishing partnership with the American Institute of Chemical Engineers
9. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
10. News tips from ACS Chemical Biology
11. American Chemical Societys Weekly PressPac -- June 20, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chemical link indicated between drinking and certain cancers

(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... Water Center today awarded 12 research grants, totaling ... protection efforts. , The two-year grants of up ... to track the remediation of harmful algae blooms; ... weedy plant invasions; study chromosomal damage in tree ... activities. , The grants were awarded to multidisciplinary ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... May 21, 2013 Possible mold re-infestation in ... according to a report from eagletribune.com posted May 14, 2013, ... case the result is positive, My Cleaning Products offered a ... chemical ingredients. , It was said in the Eagle Tribune ... in the campus sparked after a first-grade classroom was closed ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: